ATR vs SRPT · P/E 21, rev $2.01B vs rev $1.13B
AptarGroup Inc (ATR) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
AptarGroup Inc (ATR) is a medical instruments & supplies company listed on NYSE.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported ATR revenue for 2026-06-30 was $2.01B. Net income was $160.2M. ATR currently screens at market cap $7.66B and trailing P/E 20.5.
Latest reported SRPT revenue for 2026-06-30 was $1.13B. Net income was $326.1M. Revenue was up 54.9% from 2026-03-31 to 2026-06-30. SRPT currently screens at market cap $2.34B.
ATR currently screens at market cap $7.66B and trailing P/E 20.5. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the ATR and SRPT stock pages for the full models.
Not investment advice.